Wen-Fang Tang

Years Active: 2021-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Fang Tang, Xiao-Jun Fan, Hua Bao, Rui Fu, Yi Liang, Min Wu, Chao Zhang, Jian Su, Yi-Long Wu, Wen-Zhao Zhong
Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer. Oncoimmunology 12 (1) (2023)
Zhi-Yong Chen, Rui Fu, Xiao-Yue Tan, Li-Xu Yan, Wen-Fang Tang, Zhen-Bin Qiu, Yi-Fan Qi, Yu-Fa Li, Qing-Yi Hou, Yi-Long Wu, Wen-Zhao Zhong, Ben-Yuan Jiang
Dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer. Thoracic cancer 13 (17) (2022)
Wen-Fang Tang, Wei Xu, Wei-Zhao Huang, Gui-Nan Lin, Yu-Mei Zeng, Jie-Shan Lin, Min Wu, Hua Bao, Jie-Wen Peng, Hai-Ming Jiang, Heng-Qiang Wang, Ying-Meng Wu, Hong-Yu Ye, Yi Liang
Pathologic complete response after neoadjuvant tislelizumab and chemotherapy for Pancoast tumor: A case report. Thoracic cancer 12 (8) (2021)
Xiang-Peng Chu, Zi-Hao Chen, Shao-Min Lin, Wen-Fang Tang, Jia-Tao Zhang, Yao-Ming Lai, Rui Fu, Zhen-Bin Qiu, Jun-Tao Lin, Qiang Nie, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong
Precise resection of multiple pulmonary nodules using a three-dimensional reconstruction model: A case report. Thoracic cancer 12 (6) (2021)
Wen-Fang Tang, Rui Fu, Yi Liang, Jie-Shan Lin, Zhen-Bin Qiu, Yi-Long Wu, Wen-Zhao Zhong
Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives. Cancer communications (London, England) (2021)

Wen-Fang Tang.css-eqlu8i{font-size:small;padding-left:4px;}